151843-04-8

Basic information

• Product Name: .beta.-D-Galactopyranoside, 4-hydroxybutyl 6-O-.beta.-D-galactopyranosyl-
• Synonyms: .beta.-D-Galactopyranoside, 4-hydroxybutyl 6-O-.beta.-D-galactopyranosyl-
• CAS NO: 151843-04-8
• Molecular Formula: C16H30 O12
• Molecular Weight: 0
• Mol File: 151843-04-8.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: .beta.-D-Galactopyranoside, 4-hydroxybutyl 6-O-.beta.-D-galactopyranosyl-(CAS DataBase Reference)
• NIST Chemistry Reference: .beta.-D-Galactopyranoside, 4-hydroxybutyl 6-O-.beta.-D-galactopyranosyl-(151843-04-8)
• EPA Substance Registry System: .beta.-D-Galactopyranoside, 4-hydroxybutyl 6-O-.beta.-D-galactopyranosyl-(151843-04-8)

Safety Data

• Hazardous Substances Data: 151843-04-8(Hazardous Substances Data)

Usage

Description

.beta.-D-Galactopyranoside, 4-hydroxybutyl 6-O-.beta.-D-galactopyranosylis a chemical compound that consists of a galactose molecule attached to a 4-hydroxybutyl group. It is commonly used in research and laboratory settings as a substrate for enzymatic reactions, particularly those involving glycosidases and glycosyltransferases. .beta.-D-Galactopyranoside, 4-hydroxybutyl 6-O-.beta.-D-galactopyranosylhas been studied for its potential applications in drug delivery systems and as a substrate for the synthesis of various glycosides. Additionally, it has been investigated for its role in the formation of glycosidic bonds and its potential therapeutic applications in the treatment of lysosomal storage disorders.

Uses

Used in Research and Laboratory Settings:
.beta.-D-Galactopyranoside, 4-hydroxybutyl 6-O-.beta.-D-galactopyranosylis used as a substrate for enzymatic reactions in research and laboratory settings for studying the activity and specificity of glycosidases and glycosyltransferases. This application helps researchers understand the mechanisms of these enzymes and their roles in various biological processes.
Used in Drug Delivery Systems:
In the pharmaceutical industry, .beta.-D-Galactopyranoside, 4-hydroxybutyl 6-O-.beta.-D-galactopyranosylis used as a component in the development of drug delivery systems. Its ability to form glycosidic bonds makes it a promising candidate for targeted drug delivery, potentially improving the efficacy and specificity of therapeutic agents.
Used in Synthesis of Glycosides:
.beta.-D-Galactopyranoside, 4-hydroxybutyl 6-O-.beta.-D-galactopyranosylis also used as a substrate for the synthesis of various glycosides in the chemical industry. These glycosides have a wide range of applications, including pharmaceuticals, cosmetics, and the food industry, due to their diverse biological activities and properties.
Used in Treatment of Lysosomal Storage Disorders:
.beta.-D-Galactopyranoside, 4-hydroxybutyl 6-O-.beta.-D-galactopyranosylhas been investigated for its potential therapeutic applications in the treatment of lysosomal storage disorders. These disorders are caused by the accumulation of undigested materials within lysosomes, and the compound's role in the formation of glycosidic bonds may help in the development of treatments to address these conditions.